Td Waterhouse Canada Inc. Pro Qr Therapeutics N.V. Transaction History
Td Waterhouse Canada Inc.
- $12.4 Trillion
- Q4 2024
A detailed history of Td Waterhouse Canada Inc. transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 40 shares of PRQR stock, worth $90. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40
Previous 40
-0.0%
Holding current value
$90
Previous $70,000
51.43%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PRQR
# of Institutions
80Shares Held
40MCall Options Held
10.7KPut Options Held
24.1K-
Adage Capital Partners Gp, L.L.C. Boston, MA9.6MShares$21.7 Million0.05% of portfolio
-
Privium Fund Management B.V.4.99MShares$11.3 Million3.12% of portfolio
-
Woodline Partners LP San Francisco, CA3.56MShares$8.04 Million0.07% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.83MShares$6.39 Million0.0% of portfolio
-
Affinity Asset Advisors, LLC New York, NY2.83MShares$6.38 Million1.38% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $161M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...